An application of integrative medicine: nutritional and other therapies can assist with co-occurring substance use and eating disorders.Eating disorders (EDs) such as bulimia nervosa and anorexia nervosa involve many features similar to those present in substance use disorders (SUDs). Both involve a preoccupation with a substance and with the behaviors accompanying the addiction. Both involve some impulse control issues and the inability to stop doing something that is harmful or addictive. In individuals with bulimia, impulse control issues might include sexual promiscuity, bingeing and the use of drugs and alcohol. Individuals with anorexia exert excessive control to the point of self-starvation and are unable to stop their impulse to restrict. [ILLUSTRATION OMITTED] A review of studies on the co-occurrence of eating disorders and substance use disorders showed that 23% of individuals with bulimia reported alcohol abuse, with 26% reporting drug abuse. For anorexics, the prevalence of drug use was 19%. Of those with a SUD SUD 1. Substance use disorder 2. Sudden unexpected or unexplained death. See Sudden unexplained nocturnal death. , 8 to 20% have a current or past history of bulimia and 2 to 10% have a current or past history of anorexia. (1) Between 50 and 70% of individuals with bulimia have a SUD. Binge eating is associated with heavier use of substances as well as higher rates of depression and low self-esteem. (2) Those with bulimia and alcohol dependence have higher rates of suicide attempts and anxiety disorders and are more likely to use other drugs and have borderline or histrionic personality disorders. (3) SUDs appear to be higher in ED patients than in healthy controls. (4) Integrative medicine is a healing-oriented discipline that takes into account the whole person--body, mind and spirit--including all aspects of lifestyle. It emphasizes the therapeutic relationship and makes use of both conventional and alternative therapies. While integrative therapies have not been considered part of a traditional approach to the treatment of either eating disorders or substance use disorders, they can be beneficial in the treatment of these co-occurring disorders. The remainder of this article will discuss some of the most promising therapies. Nutritional strategies Nutritional therapies are essential in treating EDs but also have a place in SUD treatment. Individuals with SUDs often eat poorly, which limits absorption of vitamins and minerals needed to maintain essential body functions. Approximately 80% of ED clients and two-thirds of those with SUDs will experience depression in their lifetime, and individuals with depression also have nutritional deficits. Several categories of nutritional therapies are potentially useful. Omega-3 fatty acids This is a list of omega-3 fatty acids. Common name Lipid name Chemical name α-Linolenic acid (ALA) 18:3 (n-3) octadeca-9,12,15-trienoic acid Stearidonic acid 18:4 (n-3) octadeca-6,9,12,15-tetraenoic acid are essential fatty acids Essential fatty acids Sources of fat in the diet, including omega-3 and omega-6 fatty acids. Mentioned in: Nutritional Supplements because the body cannot manufacture them. EPA EPA eicosapentaenoic acid. EPA abbr. eicosapentaenoic acid EPA, n.pr See acid, eicosapentaenoic. EPA, n. (eicosapentaenoic acid) and DHA DHA docosahexaenoic acid. DHA, n.pr See acid, docosahexaenoic. (docosahexaenoic acid) are omega-3 fatty acids found in cold-water fatty fish (such as salmon, tuna, mackerel and sardines) and fish oil. Vegetarian sources of fatty acids come from algae algae (ăl`jē) [plural of Lat. alga=seaweed], a large and diverse group of primarily aquatic plantlike organisms. These organisms were previously classified as a primitive subkingdom of the plant kingdom, the thallophytes (plants that or from walnuts and flaxseeds (which must be fresh ground) and contain a precursor to DHA and EPA called alpha-linolenic acid (ALA). Populations with the highest seafood intake have the lowest levels of illnesses such as major depression and bipolar disorder. Omega-3 fatty acids have been shown to decrease the risk of and/or treat depression and schizophrenia and to decrease aggression and hostility in borderline personality disorder bor·der·line personality disorder n. A personality disorder marked by a long-standing pattern of instability in interpersonal relationships, behavior, mood, and self-image that can interfere with social or occupational functioning or cause extreme . (5) [ILLUSTRATION OMITTED] Typical dosages range from 2 to 5 grams per day. One note of caution: There is a theoretical risk of bleeding in individuals who are taking blood thinners, although there have been no reported cases. B-vitamins, including B-12, folic acid and B-6 (pyridoxine pyridoxine: see coenzyme; vitamin. ), are required for the synthesis of neurotransmitters in the brain. Individuals with depression and alcoholics have low levels of B-12 and folic acid as well as other B-vitamins. Supplementation with folate folate /fo·late/ (fo´lat) 1. the anionic form of folic acid. 2. more generally, any of a group of substances containing a form of pteroic acid conjugated with l-glutamic acid and having a variety of substitutions. may increase the effectiveness of antidepressants (6) and low levels of folate are implicated in poor response to antidepressant therapy. (7) A B-complex vitamin taken once a day can be used to obtain adequate amounts of all the B-vitamins. Vitamin D is important because alcoholics and some individuals with EDs are at higher risk for bone loss and osteoporosis. Vitamin D is an important nutrient for bone health. Sources for vitamin D besides conversion in the skin by sunlight include foods such as cereals or milk products. Another source is cod liver oil cod liver oil an oil pressed from the fresh liver of the cod and purified. It is one of the best-known natural sources of vitamin D, and a rich source of vitamin A. Because cod liver oil is more easily absorbed than other oils, it was formerly widely used as a nutrient and tonic, . Egg yolks, beef liver and cheese contain small amounts as well. There is some newer preliminary evidence supporting the use of Vitamin D-3 (cholecalciferol cholecalciferol /cho·le·cal·ci·fer·ol/ (ko?le-kal-sif´er-ol) vitamin D; a hormone synthesized in the skin on irradiation of 7-dehydrocholesterol or obtained from the diet; it is activated when metabolized to 1,25-dihydroxycholecalciferol. ) over Vitamin D-2 (ergocalciferol ergocalciferol /er·go·cal·cif·er·ol/ (er?go-kal-sif´er-ol) vitamin D; a sterol occurring in fungi and some fish oils or synthesized from ergosterol, with similar activity and metabolism to those of cholecalciferol; used as a dietary ). Alcohol consumption interferes with the production of vitamin D. Certain medications may lower vitamin D levels as well. These include Dilantin (used for seizures), steroid medications such as prednisone prednisone (prĕd`nĭsōn): see corticosteroid drug. used to reduce inflammation or treat asthma, and Questran (cholestyramine cholestyramine /cho·le·sty·ra·mine/ (ko?le-sti´rah-men) see cholestyramine resin, under resin. cho·le·styr·a·mine n. ), a cholesterol-lowering medication. A dosage of 1,000 IU daily is appropriate for Vitamin D-3. Amino acids also have become more widely used. Research has documented that the dopaminergic dopaminergic /do·pa·min·er·gic/ (do?pah-men-er´jik) activated or transmitted by dopamine; pertaining to tissues or organs affected by dopamine. do·pa·mi·ner·gic adj. system, especially the dopamine D2 receptor, is implicated in the reward cascade stimulated by natural rewards as well as by the use of psychoactive substances. This cascade affects levels of dopamine in the brain, which can be modified by other neurotransmitters such as serotonin, norepinephrine norepinephrine (nôr'ĕpīnĕf`rən), a neurotransmitter in the catecholamine family that mediates chemical communication in the sympathetic nervous system, a branch of the autonomic nervous system. and GABA GABA ?. GABA abbr. gamma-aminobutyric acid GABA (gamma-aminobutyric acid) A neurotransmitter that slows down the activity of nerve cells in the brain. . Researchers have proposed that defects in this system can result in a reward deficiency syndrome and that adults with this syndrome are at higher risk for abuse of psychoactive substances. (8) Amino acids, the building blocks of protein, are used to manufacture the neurotransmitters listed above. Many with EDs and SUDs continue to crave their substance or process even after achieving abstinence for an extended period. It is postulated that this might be a result of reward deficiency syndrome and that supplementation of the amino acid precursors to neurotransmitters might reduce these symptoms and decrease relapse. Eight of the 20 amino acids are essential, meaning they must be consumed in our diet. For example, adrenaline/noradrenaline is made from the amino acids L-phenylalanine and tyrosine; endorphins endorphins (ĕndôr`fĭnz), neurotransmitters found in the brain that have pain-relieving properties similar to morphine. There are three major types of endorphins: beta endorpins, found primarily in the pituitary gland; and enkephalins and are made from D- and DL-phenylalanine; serotonin is made from tryptophan tryptophan (trĭp`təfăn), organic compound, one of the 20 amino acids commonly found in animal proteins. Only the l-stereoisomer appears in mammalian protein. or 5-HTP. Symptoms that may be part of reward deficiency syndrome include anxiety, stress or tension, which may respond to supplementation with GABA, tryptophan, 5-HTP or taurine taurine /tau·rine/ (taw´ren) an oxidized sulfur-containing amine occurring conjugated in the bile, usually as cholyltaurine or chenodeoxycholyltaurine; it may also be a central nervous system neurotransmitter or neuromodulator. . Difficulty concentrating, mental fuzziness, memory problems, depression with apathy and low energy may respond to tyrosine. Hypersensitivity to stimuli (light, noise) and chronic pain may respond to DL-phenylalanine. Insomnia or irritability may respond to 5-HTP or GABA or taurine. Furthermore, clinical observations have demonstrated specific amino acid deficiency symptoms that are particular to the drug of abuse: * Stimulant abuse: tyrosine. * Alcoholism: tryptophan, GABA. * Opiate dependence: D-phenylalanine, GABA and tryptophan or 5-HTP. * Carbohydrate cravings: tryptophan/5-HTP, tyrosine and DL-phenylalanine. Amino acids should be taken along with B-vitamins as noted above. (9) Therapies for stress Stress is considered a major factor in the initiation, continuation and relapse of SUDs and EDs. The use of body-centered therapies can reduce physiological measures of stress and reduce symptoms of mood and anxiety disorders. Massage reduces anxiety in anorexic women and reduces withdrawal symptoms in adults trying to quit smoking. Massage during alcohol withdrawal, when combined with conventional treatment, improves engagement in therapy. Massage therapy is also useful in treating depression and eating disorders. (10) Acupuncture may reduce relapse from alcohol. In one study, 93.75% of participants who received acupuncture and conventional treatment were abstinent, vs. 42.86% of a control group that received conventional treatment alone. (11) Acupuncture may be helpful in the treatment of co-occurring disorders seen in both EDs and SUDs, such as depression, anxiety and the symptoms of post-traumatic stress disorder post-traumatic stress disorder (PTSD), mental disorder that follows an occurrence of extreme psychological stress, such as that encountered in war or resulting from violence, childhood abuse, sexual abuse, or serious accident. (PTSD PTSD posttraumatic stress disorder. PTSD abbr. posttraumatic stress disorder Post-traumatic stress disorder (PTSD) ). Acupuncture has shown promise in research in reducing withdrawal symptoms and cravings in alcoholics, opiate addicts and cocaine addicts. Relaxation therapies include guided imagery, biofeedback biofeedback, method for learning to increase one's ability to control biological responses, such as blood pressure, muscle tension, and heart rate. Sophisticated instruments are often used to measure physiological responses and make them apparent to the patient, who , meditation and breath work, which may be helpful in treating depression and anxiety. Meditation may reduce drug use (12), and guided imagery may reduce bingeing and purging in BN. (13) Sleep aids Sleep problems are common in individuals with SUDs and EDs. Difficulty sleeping may have a negative impact on treatment and on relapse risk. The use of progressive relaxation training reduced complaints of sleep disturbances in alcoholics. (14) Valerian valerian, in botany valerian, common name for some members of the Valerianaceae, a family chiefly of herbs and shrubs of temperate and colder regions of the Northern Hemisphere; a few species, however, are native to the Andes. root was useful in decreasing complaints of sleep problems in an inpatient setting in patients with co-occurring EDs and SUDs, reducing the need for prescription medication from 53% to 13%. (15) Valerian root can cause an increase in sedation when used with benzodiazepines Benzodiazepines Definition Benzodiazepines are medicines that help relieve nervousness, tension, and other symptoms by slowing the central nervous system. Purpose Benzodiazepines are a type of antianxiety drugs. or alcohol, and it has a characteristic "stinky" odor. The dosage for insomnia is 900 mg at bedtime; safety has been established for use up to 28 days. Conclusion Eating disorders and substance use disorders co-occur at very high rates. The mediating factor may be genetics or possibly mood and anxiety disorders. Research on the use of alternative therapies in individuals with ED or SUD is ongoing. The therapies are often low in risk when used appropriately. Integrative medicine, while not considered part of traditional treatment for ED and SUD, can offer significant benefits in conjunction with conventional therapies. References (1.) Holderness CC, Brooks-Gunn J, Warren MP. Co-morbidity of eating disorders and substance abuse: review of the literature. Int J Eat Disord 1994 Jul; 16:1-34. (2.) Ross HE, Ivis F. Binge eating and substance use among male and female adolescents. Int J Eat Disord 1999 Nov; 26:245-60. (3.) Bulic CM, Sullivan PF. Lifetime comorbidity of alcohol dependence in women with bulimia nervosa. Addict Behav 1997 Jul-Aug; 22:437-46. (4.) Krug I, Treasure J, Anderluh M, et al. Present and lifetime comorbidity of tobacco, alcohol and drug use in eating disorders: a European multicenter study. Drug Alcohol Depend 2008 Sep l; 97:l69-79. (5.) Hutchins H. Symposium Highlights--Omega-3 fatty acids: recommendations for therapeutics and prevention. Medscape CME CME See: Chicago Mercantile Exchange CME See Chicago Mercantile Exchange (CME). . Published Oct. 19, 2005. (6.) Taylor MJ, Carney SM, Geddes J, et al. Folate for depressive disorders. Cochrane Database of Systematic Reviews. 2005, Issue 2. (7.) Coppen A, Bailey J. Enhancement of the antidepressant action of fluoxetine fluoxetine /flu·ox·e·tine/ (floo-ok´se-ten) a selective serotonin reuptake inhibitor used as the hydrochloride salt in the treatment of depression, obsessive-compulsive disorder, bulimia nervosa, and premenstrual dysphoric disorder. by folic acid: a randomized ran·dom·ize tr.v. ran·dom·ized, ran·dom·iz·ing, ran·dom·iz·es To make random in arrangement, especially in order to control the variables in an experiment. , placebo-controlled trial. J Affect Disord 2000 Nov; 60:121-30. (8.) Comings DE, Blum K. Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog Brain Res 2000; 126:325-41. (9.) Holford P, Miller D, Braly J. How to Quit Without Feeling S**t: The Fast, Highly Effective Way to End Addiction to Caffeine, Sugar, Cigarettes, Alcohol, Illicit or Prescription Drugs. London: Piatkus Books; 2008. (10.) Hart S, Field T, et al. Anorexia nervosa symptoms are reduced by massage therapy. Eat Disord 2001 Winter; 9:289-99. (11.) He-Hon L. A retrospective study on the use of acupuncture for the prevention of alcoholic recidivism recidivism: see criminology. . Am J Acupuncture 1996; 23:29-33. (12.) Gelderloos P, Walton KG, Orme-Johnson DW, et al. Effectiveness of the Transcendental Meditation program in preventing and treating substance misuse: a review. Int J Addict 1991 Mar; 26:293-325. (13.) Esplen MJ, Garfinkel PE. Guided imagery treatment to promote self-soothing in bulimia nervosa: a theoretical rationale. J Psychother Pract Res 1998 Spring; 7:102-18. (14.) Greeff AP, Conradie WS. Use of progressive relaxation training for chronic alcoholics with insomnia. Psychol Rep 1998 Apr; 82:407-12. (15.) Ross C, Herman PM, Rocklin O, et al. Evaluation of integrative medicine supplements for mitigation of chronic insomnia and constipation in an inpatient eating disorders setting. Explore (NY) 2008 Sep-Oct; 4:315-20. BY CAROLYN COKER ROSS, MD, MPH Carolyn Coker Ross, MD, MPH, is an author, speaker and expert in the field of eating disorders, addictions and integrative medicine. Now in private practice, she formerly headed the eating disorders program at Sierra Tucson and is now a consultant at The Ranch outside of Nashville, Tennessee. Her e-mail address is crossmd@mac.com and her Web site is www.carolynrossmd.com. |
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion